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Abstract
Designing new molecules with a set of predefined properties is a core problem in
modern drug discovery and development. There is a growing need for de-novo
design methods that would address this problem. We present MolecularRNN, the
graph recurrent generative model for molecular structures. Our model generates
diverse realistic molecular graphs after likelihood pretraining on a big database
of molecules. We perform an analysis of our pretrained models on large-scale
generated datasets of 1 million samples. Further, the model is tuned with policy
gradient algorithm, provided a critic that estimates the reward for the property of
interest. We show a significant distribution shift to the desired range for lipophilic-
ity, drug-likeness, and melting point outperforming state-of-the-art works. With
the use of rejection sampling based on valency constraints, our model yields 100%
validity. Moreover, we show that invalid molecules provide a rich signal to the
model through the use of structure penalty in our reinforcement learning pipeline.
1 Introduction
The process of discovering a new drug candidate, passing it through clinical trials and onto the market
is extremely hard, time-consuming, and expensive. Less than one out of every 10,000 drug candidates
becomes an approved marketed drug. Only three out of every 20 approved drugs bring in enough
revenue to cover developmental costs. Moreover, it takes approximately 10-15 years and the average
cost of $1-3 billion to develop each new drug. The development of computer algorithms can help in
this process, for example, by suggesting novel molecules with optimal property profiles. This process
is called de novo molecular design. The goal of de novo methods is to create novel molecules with
desired properties. It typically comprises from three tasks: 1) molecule generation; 2) scoring, and 3)
optimization [Schneider and Fechner, 2005]. Each of these steps could be performed sequentially or
together by either human expert or machine.
Machine learning systems are radically transforming the practice of chemical and molecular sciences
[Butler et al., 2018]. Drug discovery is well positioned to be the next frontier for a potential
breakthrough. Not surprisingly, recent advances in machine learning methods have also facilitated the
automated generation of new molecules with the desired properties. Recently we have seen a huge
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rise due to deep neural networks, which are now well-developed and optimized for continuous signals
with naturally defined neighborhoods for the simplest elements. For example, pixels are grouped
in local neighborhoods in images with convolutional neural networks, and words are grouped in
natural language with recurrent neural networks. However, graphs are a more complex structure with
non-uniform neighborhoods, for which networks have been introduced not so long ago.
While there exist several representations of molecules (SMILES, fingerprints, 3D atom configuration),
graphs are the most natural one, with direct mapping of atoms into nodes, and bonds into edges.
A molecular graph is undirected but has several node types (carbon, oxygen, nitrogen, etc.), as
well as edge types (single, double, triple, and aromatic bond). Other representations suffer from
being complicated and lacking a clear notion of distance. For example, SMILES (natural language
representation of a molecule in the form of a string), adds a layer of complexity with its grammatical
rules, but more importantly, a pair of molecules which share a common scaffold (core), can be
encoded by very different SMILES strings representations. We introduce a molecular graph recurrent
generative model, showing that incremental molecular graph construction seamlessly incorporates
the proposed valency-based rejection sampling procedure that yields 100% valid molecules during
inference, while also getting signal from invalid intermediate molecules through our structural penalty.
After training our model in an unsupervised manner to match the distribution of large training datasets,
optimizing properties is particularly interesting for application. We show the capability of optimizing
the generated molecules to a specific property range through reinforcement learning, where the reward
is constructed based on the output of a critic.
We summarize our main contributions as the following:
• molecular graph recurrent model, MolecularRNN, for direct generation of realistic molecular
graph structures that shows high validity/uniqueness/novelty
• valency-based rejection sampling method during inference that produces 100% valid
molecules, and the structural penalty during training for atoms violating valency constraints
• target property optimization with reinforcement learning for improving drug-likeness,
lipophilicity, and melting temperature
• an unprecedented large-scale experimental analysis and application through amalgamation
of these techniques.
2 Related work
Various approaches to computational de-novo molecule generation have been proposed. The funda-
mental differences in these approaches lie in types of molecules representation. The most well-studied
way to represent a chemical molecule is a simplified molecular-input line-entry system (SMILES)
string [Weininger, 1988]. SMILES string consists of symbols corresponding to nodes of the molecu-
lar graph in their depth-first order, unambiguously describing the composition and structure of the
chemical molecule. Approaches for generating molecules as SMILES strings are using a recurrent
neural network to learn a language model of SMILES [Olivecrona et al., 2017, Gómez-Bombarelli
et al., 2018, Popova et al., 2018]. Probably the biggest limitation of these methods is imperfect
validity (i.e. some of the generated samples are not chemically valid molecules) due to a challenge of
learning complex grammatical rules. Another limitation is that SMILES-based approaches cannot be
naturally extended to scaffold optimization when a generation process starts from a given core of the
molecule and the task is to find a molecule with better properties and pattern of substituents while
maintaining the same molecular core.
Another way to represent a chemical molecule is through its molecular graph. Graph-based approaches
typically do not suffer from the problem of invalidity of generated molecules. It is also possible to
enforce physical constraints on the valency, i.e., how many neighbors each atom can have depending
on the atom type. Moreover, these models are more interpretable and more intuitive to chemists.
Various algorithms for generating molecular graphs have been developed [Jin et al., 2018, Li et al.,
2018a]. Jin et al. [2018] proposed a junction tree variational autoencoder. This model first generates
a junction tree where every node corresponds to a structural fragment rather than a single atom. Then,
the junction tree is converted into a valid molecule with a sampling procedure. This approach produces
valid molecules by design; however, there is ambiguity in the process of converting a generated
junction tree into a molecule due to sampling. While this is not a problem for the unconstrained
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generative process, it may cause difficulties with property optimization because molecules with the
same junction tree may have a drastic difference in property value. Jin et al. [2018] argue that it is
beneficial to generate a graph from fragments, however, atom-by-atom models have already proven
as a strong baseline [You et al., 2018a, Liu et al., 2018, Li et al., 2018b]. In [Li et al., 2018a] the
process of graph generation is sequential. Nodes are generated one at a time and then connected to
the existing partial graph. With a sequential process, the same graph can be generated with multiple
sequences of steps due to the node order permutation. This work does not address the problem of
node order permutation. Another limitation of this work is the constraints on the graph size. Only
molecular graphs with at most 20 heavy atoms were considered which is not enough for any practical
purpose.
In [You et al., 2018a], the procedure of molecular graph generation is presented as a Markov
Decision Process. The model uses graph convolutional network (GCN) model for goal-directed graph
generation with reinforcement learning and adversarial training. This work similar to [Jin et al., 2018]
only reports top 3 molecules, while top 3 may not represent the model performance as well as the
distribution of a property obtained from a large number of generated samples. Recently, GraphRNN
model [You et al., 2018b] was proposed for the generation of undirected graphs. We extend this
model to include node and edge types predictions.
Previous works have explored a variety of methods to optimize properties of interest for molecules:
fine-tuning [Olivecrona et al., 2017], transfer learning [Segler et al., 2017], reinforcement learning
[Popova et al., 2018] and adversarial training [Kadurin et al., 2017]. Often physicochemical properties,
such as the octanol-water partition coefficient (logP) and molecular weight (MW), melting temperature
(Tmelt) are used as a convenient proxy for drug-likeness and chances of a particular molecule for the
successful drug candidate.
3 Methods
The core of our approach is a MolecularRNN model, which extends GraphRNN [You et al., 2018b]
model for generating graphs with node and edge types. Section 3.1 gives background on GraphRNN,
and the extension is described in Section 3.2. We introduce a method of valency-based rejection
sampling in Section 3.3 that yields 100% validity in inference mode. We show a distribution shift
towards desired properties values with reinforcement learning in Section 3.4. Finally in Section 3.5
we introduce our structural penalty that provides a signal from the invalid samples during training.
3.1 Background: GraphRNN model
GraphRNN [You et al., 2018b] was introduced for generation of undirected graphs G = (V,E)
with a set of n nodes V = (v1, . . . , vn) and a set of undirected edges E = ({vi, vj}|vi, vj ∈ V )
between those nodes. Under some node ordering pi this graph is represented with its adjacency
matrix Api ∈ {0, 1}n×n with Apii,j = 1 iff (pi(vi), pi(vj)) ∈ E. The model generates graphs as
sequences of adjacency vectors Spii ∈ {0, 1}i−1 from node pi(vi) to previous nodes under pi. Thus,
Spii =
(
Api1,i, . . . A
pi
i−1,i
)T
, and likelihood p(Spi) can be modelled sequentially, being decomposed as
p(Spi) =
n+1∏
i=1
p(Spii |Spi1 , . . . , Spii−1) =
n+1∏
i=1
p(Spii |Spi<i) (1)
with the special end of sequence token (EOS) as an extra node n+ 1.
State-transition function carries the information from step i − 1 to step i, generating a node, and
output function predicts the parameters for sampling current adjacency vector Spii of edges. According
to GraphRNN, we consider recurrent neural networks for both state-transition function (NodeRNN)
and output function (EdgeRNN). Thus, NodeRNN unrolls across nodes, updating its hidden state,
while EdgeRNN unrolls across edges from i to previous nodes, creating parameters θi,j with the use
of a small MLP head with sigmoid activation, which models Spii as a dependent Bernoulli sequence:
hnodei = NodeRNN(h
node
i−1 , S
pi
i−1), h
node
0 = 0
hedgei,j = EdgeRNN(h
edge
i,j−1, S
pi
i,j−1), h
edge
i,0 = h
node
i
θi,j = EdgeMLP(h
edge
i,j )
(2)
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One of the key insights of the method is to re-order the nodes with breadth-first search (BFS), starting
from pi(v1), which gradually reduces the space complexity for graph representations. Moreover,
BFS order also reduces the number of edge predictions that have to be made, limiting the size of
Spii to M dimensions, which appears to be a small number in practical tasks. Thus, for our modified
MolecularRNN (Section 3.2) we empirically establish M = 12.
3.2 MolecularRNN
In order to represent a molecule with a graph, atoms are mapped to nodes, while bonds are mapped
to edges. Now, adjacency vector entries represent categorical bond types Spii,j ∈ {0, 1, 2, 3}, cor-
responding to no, single, double, and triple bonds (molecules are modeled in kekulized form as
defined in RDKit [Landrum et al., 2006]). Similarly, categorical type Cpii ∈ {1, 2, . . . ,K} (oxygen,
nitrogen, chlorine, etc.) is assigned to each node. Notice that here a node always has a valid atom
class. That is, there is no "terminal node" class, as terminal node notion is already incorporated into
Spii . Specifically, when a node is generated that has no edges to any of the previous nodes, such a
node is terminal. Atom class prediction is ignored for this node in our setting.
Likelihood in Equation 1 is rewritten accordingly for MolecularRNN:
p(Spi, Cpi) =
n+1∏
i=1
p(Cpii |Spi<i, Cpi<i)p(Spii |Cpii , Spi<i, Cpi<i), (3)
with p(Cn+1|S<n+1, C<n+1) ≡ 1 for the terminal node n+ 1.
In our model, once the sub-graph on the first i−1 nodes under permutation pi is completed, NodeRNN
can momentarily decide on the atom type of the following node i. Thus, the process represents a
dependent multivariate distribution. Accounting for the sub-graph, as well as the i-th atom type, the
model switches to EdgeRNN that links the newly generated node to the set {1, . . . , i− 1}. That step
is in turn modeled with a dependent multivariate distribution, as EdgeRNN is unrolled across nodes
that precede i. Overall MolecularRNN structure is shown in Figure 1. The model uses embeddings
for categorical inputs, and a two-layer MLP with softmax output activation is added on top of hidden
states hnode and hedge for categorical prediction, so Equation 2 is modified:
inputi−1 = [emb(S
pi
i−1), emb(C
pi
i−1)]
hnodei = NodeRNN(h
node
i−1 , inputi−1), h
node
0 = 0
ψi = NodeMLP(hnodei )
hedgei,j = EdgeRNN(h
edge
i,j−1, emb(S
pi
i,j−1)), h
edge
i,0 = h
node
i
φi,j = EdgeMLP(h
edge
i,j ),
(4)
In our BFS ordering the first node is always a Carbon atom, since every organic molecule contains at
least one such atom.
3.3 Valency-based rejection sampling
As we have seen, MolecularRNN samples edge types on each sub-step from a multinomial distribution
with parameters coming out of softmax predictions. Even when the model is trained well for producing
valid molecules, the softmax layer prediction will always have nonzero values, so if sampling is
arbitrarily long, any graph can be sampled from the support space. However, real molecules have
valency constraints. That is, per-atom valency has to be respected to satisfy chemical constraints.
Consequently, in each step, we can ensure that the current sum of all bonds does not exceed the
allowed valency. When generating an edge corresponding to a bond of order k between i and j we
check the rejection sampling constraint for both atoms:
∑
j
Apii,j + k ≤ valencyCpii and
∑
i
Apii,j + k ≤ valencyCpij (5)
4
Figure 1: MolecularRNN model. The model consists of NodeRNN that unrolls across atoms,
predicting the type of the next atom in the molecular graph, and EdgeRNN that for every atom is
initialized with NodeRNN hidden state, and unrolls across preceding atoms to predict bond types.
For the final molecule, atoms that have not filled up their valencies are complemented with Hydrogens.
Notice that valency can be directly enforced only for graphs, unlike SMILES representation, where
intermediate sub-strings are not chemically meaningful.
3.4 Property optimization
While generating realistic molecules is an appealing goal, our ultimate aim is to shift the distribution
of the generated samples for some desired property. To optimize the chosen property, we use policy
gradient algorithm. In this formulation, MolecularRNN acts as a policy network which outputs
probability of the next action given the current state. The set of actions is defined as the set of atom
labels times the set of combinations of possible generated atom connection to the existing graph. The
set of states is defined as all possible sub-graphs of graphs with up to a fixed number of N nodes.
Consistently with the BFS ordering in MolecularRNN, initial state s0 is a graph of a single carbon
atom. The set of final states is defined as the set of all graphs that correspond to a valid molecule
with up to N heavy atoms. The reward r(sN ) for a final state sN (without loss of generality sN is
used even if n < N in the generated graph) is calculated with a critic. We distributed the final reward
to all intermediate steps, with the discounting factor, which proves to show more stable convergence
in our experiments. Thus, intermediate rewards r(si), 0 < i < N are obtained by discounting the
final reward with a fixed factor γ.
The transition probabilities p(si|si−1; θ) are the elements of the product in Equation 3. Given those,
we can write down the loss function for the policy gradient optimization algorithm by Williams
[1987], which is designed to maximize the expected reward:
L(θ) = −
N∑
i=1
r(sN ) · γi · log p (si|si−1; θ). (6)
3.5 Structural penalty
Valency-based rejection sampling can be used in inference, as was already described. However, the
invalid intermediate structures that are obtained during training can provide a useful signal to the
model. For example, a molecule can be almost realistic except for few invalid bonds. We introduce
an additional structure penalty for the atoms that disrespect valencies. Thus, instead of providing
a penalty for the whole molecule, we target specific atoms, which results in the modification of
parameters that respect valency constraints.
4 Experiments
To validate the quality of our results and compare those to the state-of-the-art methods we use validity,
uniqueness, novelty, internal diversity, synthetic accessibility score (SA score) [Ertl and Schuffen-
hauer, 2009] and drug-likeness score (QED) [Bickerton et al., 2012]. Validity is the percentage of
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chemically valid molecules. Uniqueness is the percentage of unique molecules in the generated pool.
Notice that uniqueness is highly dependent on the pool size, and may significantly drop for a large
generated library. In our experiments, we report uniqueness in up to a million of generated samples.
Internal diversity, as proposed in MOSES benchmark [Polykovskiy et al., 2018], is a quantitative
metric of the richness of the generated library and is calculated as the average pairwise distance
between all pairs of molecules in the library. SA score is an estimation of how hard is to synthesize
a given molecule, which also reflects its structural complexity. Molecules with a higher score will
be more complex and harder to synthesize. However, molecules with very low score might be not
complex enough to have the desired property. The values of interest for this metric are in the range
between 2 and 4. Finally, QED is a measure of drug-likeness in the range from 0 to 1.
4.1 Unsupervised likelihood training
We first pretrain MolecularRNN on a large unlabeled dataset of molecules to teach the model to
generate diverse realistic samples. Three training datasets are used: ChEMBL [Gaulton et al., 2011],
random 250k molecules from ZINC [Irwin and Shoichet, 2005] and MOSES [Polykovskiy et al.,
2018]. These three datasets have different statistics. The statistics are shown in Table 1. ChEMBL
dataset contains around 1.5 million of real bioactive molecules (every molecule has at least one
experimental bioactivity measurement) and is the most diverse out of all three datasets that we
considered. ZINC 250k random dataset contains 250 thousand molecules randomly selected from a
database of commercially available compounds [Irwin and Shoichet, 2005]. MOSES dataset contains
almost 2 million molecules that were selected from the ZINC database based on several filters to only
include molecules with drug-like properties.
Table 1: Statistics for training datasets.
ChEMBL ZINC MOSES
Number of molecules 1507869 249456 1936962
Mean molecular weight 389± 103 331± 62 307± 28
QED score 0.56± 0.21 0.73± 0.14 0.81± 0.09
SA score 2.88± 0.80 3.05± 0.83 2.45± 0.46
We considered 9 most common elements (C,N,O, F, P, S, Cl,Br, I) and 3 bond types (single,
double and triple). The number of atoms in the molecule is restricted to be from 10 to 50, which is
chosen based on ChEMBL dataset, where 96% of molecules lie in this range. EdgeRNN is unrolled
(as discussed in Section 3.1) for M = 12 steps for each atom. The following architectural parameters
are used in all our settings: node embedding of size 128, edge embedding of size 16, NodeRNN
with 4 GRU layers of hidden size 256 each, 2 layer NodeMLP with 128 hidden size and ReLU
nonlinearity after the first layer, and EdgeRNN with 4 GRU layers of hidden size 128 each. During
the unsupervised phase, models are trained with Adam optimizer for 250 epochs on 4 GPUs with a
per-GPU batch size of 512. The starting learning rate is 0.001 with a multiplicative drop of 0.999
every k iterations, and k is chosen based on the dataset so that the learning rate drops to 10−5 by the
end of the training. MolecularRNN trained with the likelihood maximization on the training datasets
achieves validity rate of 65% without valency-based rejection sampling. We further used structural
penalty described in section 3.5 to shift the model towards generating molecules that respect valency
constraints. To that end, every atom that violates its valency constraints is assigned a penalty of
−10, and then the model is optimized with the policy gradient method. After training with structural
penalty, our model achieved valid rate of 90% without valency-based rejection sampling. Enabling
valency-based rejection sampling results in 100% valid rate for all models.
Table 2: Statistics for 1 million molecules generated by 3 models pretrained on 3 training datasets
Training set Valid Unique Novel IntDiv(p=1)
IntDiv
(p=2) SA score QED
ChEMBL 100 % 99.2% 99.3 % 0.895 0.890 3.67± 1.20 0.56± 0.20
ZINC 250k 100 % 99.8 % 100 % 0.892 0.887 3.60± 1.01 0.68± 0.16
MOSES 100 % 99.4 % 100 % 0.881 0.876 3.24± 0.97 0.74± 0.14
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Table 2 summarizes the results of unsupervised likelihood training of MolecularRNN on the three
datasets. Statistics are calculated on 1 million generated graphs, which is a much larger scale than
previously reported. For comparison, Jin et al. [2018] sample 5 thousand graphs, and Li et al. [2018a]
evaluate a 100 thousand set. In all cases, the model produces novel diverse realistic molecules.
We also compare our model with GCPN [You et al., 2018a] and JT-VAE [Jin et al., 2018] in Table 3
on 30K molecules generated from each method. MolecularRNN produces comparable results to the
baselines in terms of validity, uniqueness, and novelty. GCPN tends to generate overly complex, hard
to synthesize molecules (high SA score). Samples from our model are more realistic, and also have
higher internal diversity than the ones from JT-VAE.
Table 3: Comparison of MolecularRNN, GCPN [You et al., 2018a] and JT-VAE [Jin et al., 2018].
Models are trained on ZINC 250k dataset. Statistics are calculated for 30000 generated molecules.
Valid Unique Novel SA score QED InvDiv
JT-VAE [Jin et al., 2018] 99.8% 100 % 100% 3.37 0.76 0.85
GCPN [You et al., 2018a] 100% 99.97% 100% 4.62 0.61 0.90
MolecularRNN 100% 99.89% 100% 3.59 0.68 0.89
4.2 Property optimization with reinforcement learning
We performed experiments on the properties optimization of generated molecules starting with our
strong pretrained model with the policy gradient algorithm (section 3.4). We choose maximization
of penalized logP as defined in [Jin et al., 2018] and QED [Bickerton et al., 2012] starting from
MolecularRNN that is likelihood-pretrained on ZINC 250k dataset. We also performed an additional
experiment with maximization of melting temperature. Such an analysis has never been reported in
graph-based generative models before. This is an appealing exercise because it requires training an
additional model for melting temperature prediction, while logP and QED can be computed directly
from the molecular graph structure. This experiment mimics realistic drug discovery scenario, where
toxicity or bioactivity is optimized. It paves the way for further research in this important direction.
Penalized logP and QED maximization. As in [You et al., 2018a, Jin et al., 2018], we indepen-
dently maximize two properties – penalized logP and QED score. MolecularRNN is tuned for 300
iterations with a generated batch size of 512 and Adam optimizer with a constant learning rate of
10−5. The objective function in Equation 6 maximizes the following rewards:
r(mol) = 5 · logPpen(mol)
r(mol) = 10 ·QED(mol).
We use discount factor γ = 0.97. The best 3 molecules after optimization for both properties are
shown in Table 4, and demonstrates the distribution shift. In this experiment, our model outperforms
all baselines in both tasks. The top 3 molecules are shown in Figure 2. Samples with high logP
values are very realistic, as the model learned to grow a chain of aromatic rings that would very
strongly bind to a lipid membrane (high lipophilicity). This is an indicator that the model learned
some underlying physics about relationship between molecular structure and properties.
Table 4: Comparison of the top 3 scores for penalized logP and QED.
Penalized logP QED score
Methods 1st 2nd 3rd Valid 1st 2nd 3rd Valid
ZINC 4.52 4.30 4.23 100% 0.948 0.948 0.948 100%
[Guimaraes et al., 2017] 3.63 3.49 3.44 0.4% 0.896 0.824 0.820 2.2%
JT-VAE [Jin et al., 2018] 5.30 4.93 4.49 100% 0.925 0.911 0.910 100%
GCPN [You et al., 2018a] 7.98 7.85 7.80 100% 0.948 0.947 0.946 100%
MolecularRNN 10.34 10.19 10.14 100% 0.948 0.948 0.947 100%
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(a) penalized logP (b) QED
Figure 2: Top 3 molecules for MolecularRNN optimized with policy gradient
Figure 3: Distribution of maximized
QED for MolecularRNN and GCPN.
We took a step further and not only looked at molecules
with top 3 scores but also considered the full distribution
of the maximized QED for libraries generated with our
MolecularRNN and GCPN You et al. [2018a] as the best
baseline. We argue that reporting only the top 3 scores
is not the most informative benchmarking metric, since
top 3 may not reflect the real performance of the model.
Instead, we encourage reporting the statistics of the opti-
mized distribution. Figure 3 shows that MolecularRNN
shifts the distribution father to the maximum values of
QED compared to GCPN.
Melting temperature maximization. We train a graph convolution regression model introduced
in [Kipf and Welling, 2016] for predicting the melting point of a molecule. Training and test datasets
were 37940 and 9458 objects correspondingly; with Tmelt ranging from −196◦C to 517◦C. The
model has 4 layers with hidden sizes of 128. We use Adam optimizer, starting with a learning rate
of 0.001 and exponential decay with γ = 0.8 after every epoch. The model is trained with a batch
size of 32 for 30 epochs. The model converges to RMS error of 39.5◦C, that is comparable to the
state-of-the-art for the same dataset [Tetko et al., 2014]. This model is then used to assign a reward
function r(mol) = exp(tpred(mol) + 1), where tpred(mol) is the normalized predicted melting
temperature for a molecule.
For this experiment, we used model pretrained on ChEMBL dataset and optimized it with the same
settings as in the previous experiments – 300 iterations with a batch size of 512 and Adam optimizer
with a constant learning rate of 10−5. Figure 4a shows the relative distribution shift of predicted
property for the molecules sampled from the pretrained model and for the molecules sampled from
the optimized model. Example of generated molecules with predicted values of Tmelt are shown
in Figure 4b. Interestingly, in this experiment, MolecularRNN rediscovered two known chemical
phenomena. First, fusing multiple aromatic rings significantly increases the Tmelt. Second, the
presence of C=O, OH, NH2 and heterocyclic nitrogens make molecules more polar. This usually
enhances dipole-dipole interactions and subsequently increase Tmelt as well.
(a) Distribution of predicted melting temperature
for base and optimized models
(b) Examples of generated molecules with highest
melting temperature
Figure 4: Melting temperature maximization
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5 Summary
We proposed MolecularRNN, the model for generating realistic molecular graphs. MolecularRNN
learns diverse distributions through unsupervised pretraining, generating 100% valid molecules in
inference, while still receiving negative feedback from invalid ones during training. Combined with
policy gradient optimization, MolecularRNN solves the problem of generating molecules with desired
properties. Optimized MolecularRNN outperforms other state-of-the-art methods on the benchmark
tasks. Furthermore, we use the predictive model as a critic to optimize melting temperature, a property
that cannot be calculated from a molecular graph. Further studies address problems of multi-objective
property optimization and completion of a molecular graph from a given scaffold.
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